Penny Stocks News (NYSE, NASDAQ, NYSEMKT)

Find the hidden catayst
Scan all pennies at once

News starting from ticker - A - (default)
PublishedDate (EST) Title
4/21/2018 7:31:41 AM     assessing gold miners’ free cash flow in 2018 and beyond
4/21/2018 7:16:00 AM     3 top biotech stocks to buy right now
4/20/2018 4:42:28 PM     are earnings prospects improving for loss-making adverum biotechnologies inc’s (nasdaq:advm)?
4/20/2018 4:40:18 PM     a look at miners’ moving averages in april 2018
4/20/2018 4:18:00 PM     semiconductor etf experiences second day of declines
4/20/2018 3:08:36 PM     how gold and silver performed amid geopolitical tensions
4/20/2018 1:00:00 PM     HOT !!:gvc capital and trickle research announce presenter schedule for rocky mountain microcap conference ii in denver on april 24, 2018
4/20/2018 10:32:19 AM     could these gold miners beat earnings estimates in 1q18?
4/20/2018 8:18:17 AM     why imf is worried about the us’s expanding debt profile
4/20/2018 8:15:00 AM     HOT !!:atossa genetics announces 1 for 12 reverse stock split
4/20/2018 7:34:13 AM     how wall street sees gold miners ahead of 1q18 earnings
4/19/2018 6:50:27 PM     is approach resources inc’s (nasdaq:arex) balance sheet strong enough to weather a storm?
4/19/2018 5:05:00 PM     HOT !!:atlantic power corporation announces repricing of aplp holdings term loan and revolver
4/19/2018 4:00:00 PM     HOT !!:air industries group announces 2018 financial guidance and final 2017 financial results
4/19/2018 12:43:15 PM     argos discontinues troubled trial, delists from nasdaq
4/19/2018 12:31:15 PM     here’s what’s dragging argos therapeutics (args) stock down today
4/19/2018 9:25:01 AM     bhp billiton (bhp) lowers iron-ore production view for fy18
4/19/2018 8:25:00 AM     recent analysis shows j.jill, bankunited, toronto dominion bank, adamis pharmaceuticals, biodelivery sciences international, and first solar market influences — renewed outlook, key drivers of growth
4/19/2018 8:00:00 AM     HOT !!:argos therapeutics reports results of interim analysis of the adapt trial and announces review of strategic alternatives
4/19/2018 7:40:00 AM     blog exposure - preclinical data presented by bayer at aacr highlights compugen’s bay 1905254 efficacy in cancer immunotherapy